Chang AJ - Search Results

1

89Zr-Radiolabeled Trastuzumab Imaging in Orthotopic and Metastatic Breast Tumors.

Chang AJ, Desilva R, Jain S, Lears K, Rogers B, Lapi S. Chang AJ, et al. Pharmaceuticals (Basel). 2012 Jan 5;5(1):79-93. doi: 10.3390/ph5010079. Pharmaceuticals (Basel). 2012. PMID: 24288044 Free PMC article.

2

Development and characterization of 89Zr-labeled panitumumab for immuno-positron emission tomographic imaging of the epidermal growth factor receptor.

Chang AJ, De Silva RA, Lapi SE. Chang AJ, et al. Mol Imaging. 2013 Jan-Feb;12(1):17-27. Mol Imaging. 2013. PMID: 23348788 Free PMC article.

3

Detection of rapalog-mediated therapeutic response in renal cancer xenografts using ⁶⁴Cu-bevacizumab immunoPET.

Chang AJ, Sohn R, Lu ZH, Arbeit JM, Lapi SE. Chang AJ, et al. PLoS One. 2013;8(3):e58949. doi: 10.1371/journal.pone.0058949. Epub 2013 Mar 14. PLoS One. 2013. PMID: 23516584 Free PMC article.

4

Video surface image guidance for external beam partial breast irradiation.

Chang AJ, Zhao H, Wahab SH, Moore K, Taylor M, Zoberi I, Powell SN, Klein EE. Chang AJ, et al. Pract Radiat Oncol. 2012 Apr-Jun;2(2):97-105. doi: 10.1016/j.prro.2011.06.013. Epub 2011 Jul 30. Pract Radiat Oncol. 2012. PMID: 24674085

5

The role of positron emission tomography for non-small cell lung cancer.

Chang AJ, Dehdashti F, Bradley JD. Chang AJ, et al. Pract Radiat Oncol. 2011 Oct-Dec;1(4):282-8. doi: 10.1016/j.prro.2011.01.001. Epub 2011 May 6. Pract Radiat Oncol. 2011. PMID: 24674007 Review.

6

Prognostic value of ¹⁸F-FDG PET metabolic parameters in oropharyngeal squamous cell carcinoma.

Garsa AA, Chang AJ, Dewees T, Spencer CR, Adkins DR, Dehdashti F, Gay HA, Thorstad WL. Garsa AA, et al. Among authors: chang aj. J Radiat Oncol. 2013 Mar;2(1):27-34. doi: 10.1007/s13566-012-0065-4. J Radiat Oncol. 2013. PMID: 24563726 Free PMC article.

7

Imaging PD-L1 Expression with ImmunoPET.

Truillet C, Oh HLJ, Yeo SP, Lee CY, Huynh LT, Wei J, Parker MFL, Blakely C, Sevillano N, Wang YH, Shen YS, Olivas V, Jami KM, Moroz A, Jego B, Jaumain E, Fong L, Craik CS, Chang AJ, Bivona TG, Wang CI, Evans MJ. Truillet C, et al. Among authors: chang aj. Bioconjug Chem. 2018 Jan 17;29(1):96-103. doi: 10.1021/acs.bioconjchem.7b00631. Epub 2017 Nov 15. Bioconjug Chem. 2018. PMID: 29125731 Free PMC article.

8

Utility of normal tissue-to-tumor α/β ratio when evaluating isodoses of isoeffective radiation therapy treatment plans.

Gay HA, Jin JY, Chang AJ, Ten Haken RK. Gay HA, et al. Among authors: chang aj. Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):e81-7. doi: 10.1016/j.ijrobp.2012.09.021. Epub 2012 Nov 7. Int J Radiat Oncol Biol Phys. 2013. PMID: 23141886

9

Clinical perspectives on dose escalation for non-small-cell lung cancer.

Chang AJ, Bradley JD. Chang AJ, et al. Clin Lung Cancer. 2010 Sep 1;11(5):299-302. doi: 10.3816/CLC.2010.n.037. Clin Lung Cancer. 2010. PMID: 20837454

10

Roles of Atox1 and p53 in the trafficking of copper-64 to tumor cell nuclei: implications for cancer therapy.

Beaino W, Guo Y, Chang AJ, Anderson CJ. Beaino W, et al. Among authors: chang aj. J Biol Inorg Chem. 2014 Mar;19(3):427-38. doi: 10.1007/s00775-013-1087-0. Epub 2014 Jan 21. J Biol Inorg Chem. 2014. PMID: 24445997 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

123 results

Search Page